Citigroup
IGC icon

Citigroup’s IGC Pharma IGC Stock Holding History

Citigroup’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.5K Buy
+46,043
New +$13.6K ﹤0.01% 5215
2018
Q4 		– Sell
-3,000
Closed -$19K – 7738
2018
Q3 		$19K Buy
+3,000
New +$3.12K ﹤0.01% 7106

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Citigroup's IGC Position: Q2 2026 in Review

Citigroup opened a new position in IGC Pharma (IGC) in Q2 2026: 46,043 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #5215 among its holdings. This is a return to the name: Citigroup previously reported a position in IGC as recently as Q3 2018.

Citigroup first reported a position in IGC in Q3 2018 and has held it in 2 quarters since. The position peaked at $19K in Q3 2018. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Citigroup held 46,043 shares of IGC Pharma worth $12.5K as of Q2 2026.
  • IGC Pharma was a new Citigroup position in Q2 2026.
  • IGC Pharma made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5215 holding.
  • Citigroup first reported a position in IGC Pharma in Q3 2018 and has held it in 2 quarters since.
  • Citigroup's IGC Pharma position peaked at $19K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.